Clinical trial Recruiting at 4 sites Observational Ages 18 to 75

Post-marketing surveillance of a femoral stem prosthesis for hip replacement

Official title: The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study

Run by Medacta International SA · NCT02748408 · Data updated 2026-11-12

This study is tracking how well a specific hip replacement device works and its safety in people aged 18 to 75 who are having hip surgery for different joint problems.

More Hip Dysplasia trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment550 (estimated)
SponsorMedacta International SA
Industry-sponsored
Locations4 sites (Vienna and 3 other locations)
StatusRecruiting
StartedJuly 2015
Main results expectedJuly 2032
Study endsJuly 2032
Registry record updatedOctober 13, 2026
Trial IDNCT02748408 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18 to 75 with severely painful hip joint conditions who are scheduled for a primary total hip replacement.

Probably not a fit

Patients with active infections, pregnancy, or certain medical conditions that may compromise their ability to participate or benefit from the study will not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study monitors the performance and outcomes of the SMS femoral stem prosthesis in patients undergoing total hip replacement. It aims to gather data on the effectiveness and safety of the prosthesis in individuals suffering from various hip joint conditions, including arthrosis and avascular necrosis. Participants will be followed for a period of 10 years to assess their progress and any potential complications associated with the implant. The study includes patients aged 18 to 75 who are scheduled for primary hip replacement surgery.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of the SMS femoral stem prosthesis, potentially improving patient outcomes in hip replacement surgeries.

How similar studies have gone: Other studies on post-marketing surveillance of orthopedic implants have shown success in monitoring long-term outcomes, suggesting this approach is validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals with a severely painful and/or disabling hip joint with osteoarthritis, traumatic arthritis or developmental dysplasia of the hip or avascular necrosis of the femoral head.
* In order to take part in this study, all study participants must be between the ages of 18 and 75 years of age, at the time of surgery.
* Scheduled for a primary total hip replacement.

Exclusion Criteria:

* Active infection
* Pregnancy
* Mental illness where the known condition is likely to compromise the patient's ability to consent, affect the patient's assessment of their progress or complete the 10 year cycle of follow-up appointments and reviews
* Grossly distorted anatomy (surgeon's discretion)
* Osteomalacia where uncemented implant fixation is contraindicated
* Active rheumatoid arthritis.
* Osteoporosis
* Metabolic disorders which may impair bone formation where uncemented implant fixation is contraindicated
* Muscular atrophy or neuromuscular disease
* Allergy to implant material
* Any patient who cannot or will not provide informed consent for participation in the study
* Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems

Where it's running

  • Herz-Jesu Krankenhaus
    Vienna, Austria
    Recruiting
  • Istituto Ortopedico Galezzi
    Milan, Milan, Italy
    Recruiting
  • Bürgerspital Solothurn
    Solothurn, Switzerland
    Recruiting
  • The Elective Orthopaedic Centre (EOC)
    Epsom, Surrey, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.